PRESS RELEASE February is the shortest month of the year. It also boasts the rarest date on the calendar: February 29, which only comes around once every four years. It’s why the date and the month have been chosen as a time to bring awareness to rare diseases.
Continue Reading
As a young child, Joseph Berretone struggled with JM. For the last ten years, however, the freshman at Duquesne University has been in remission.
Continue Reading
The Myositis Association is excited to introduce our newest staff member, Tricha Shivas. She joins TMA as Director of Development and Strategic Partnerships.
Continue Reading
TMA will be participating in Rare Disease Week on Capitol Hill February 24th- February 28th hosted by Rare Disease Legislative Advocates (RDLA). During Rare Disease Week on Capitol Hill 2019, RDLA plans to bring together over 500 patient advocates in Washington, DC for a week of events dedicated to empowering patients, families, friends, and healthcare professionals to become…
Continue Reading
Corbus Pharmaceuticals is now recruiting dermatomysitis patients for an exciting phase 3 clinical trial for lenabasum. The trial, known as DETERMINE, is designed to evaluate the efficacy and safety of lenabasum for the treatment of dermatomyositis.
Continue Reading